Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

Safety Information

91462

Sigma-Aldrich

Kollisolv® PEG E 300

Synonym(s):

Poly(ethylene glycol), Lutrol E 300, Macrogol 300, Polyethylene glycol 300, PEG

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
H(OCH2CH2)nOH
CAS Number:
25322-68-3
MDL number:
MFCD00081839
UNSPSC Code:
12352104
NACRES:
NA.25

form

liquid

Quality Level

100

mol wt

average Mw 285-315 g/mol (from OH-value (56100*2)/OHZ)

impurities

reducing substances, complies
≤0.1% sulfated ash
≤0.25% ethylene glycol and diethylene glycol (sum)
≤1 ppm ethylene oxide
≤1 ppm lead (verified on random samples only)
≤1.0% water
≤10 ppm dioxan
≤15 ppm formaldehyde
≤5 ppm heavy metals (verified on random samples only)
0.5 g acetic acid (per 100 g)
620 ppm ethylene oxide

pH

4.5-7.0 (50 g/L)

viscosity

80-105 mPa.s(20 °C) (5.4-6.4 CS (98.9°C))

hydroxyl value

340‑394 mg KOH/g

solubility

H2O: 10%, clear, colorless

suitability

complies for acidity or alkalinity

SMILES string

C(CO)O

InChI

1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2

InChI key

LYCAIKOWRPUZTN-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application

Kollisolv polyethylene glycols are used as thickening agents and gel binders in the pharmaceutical industry.
This research grade product is intended for use in R&D and development only.

Other Notes

The PEG E grades of Kollisolv are polyethylene glycols (macrogols) of different molecular weights.

Legal Information

Kollisolv is a registered trademark of BASF

Storage Class Code

10 - Combustible liquids

WGK

WGK 1

Flash Point(F)

428.0 °F - closed cup

Flash Point(C)

220.00 °C - closed cup

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

FSL

Group 4: Flammable liquids
Type 4 petroleums
Hazardous rank III

JAN Code

91462-BULK:
91462-VAR:
91462-1KG:

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BCCJ8948
BCCG6761
BCCF4164
BCCB2060
BCBW9868

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Scott N Furlan et al.
Science translational medicine, 7(315), 315ra191-315ra191 (2015-11-27)
Graft-versus-host disease (GVHD) is the most common complication of hematopoietic stem cell transplant (HCT). However, our understanding of the molecular pathways that cause this disease remains incomplete, leading to inadequate treatment strategies. To address this, we measured the gene expression
Matthew A Ingersoll et al.
Science advances, 6(49) (2020-12-04)
Hearing loss caused by noise, aging, antibiotics, and chemotherapy affects 10% of the world population, yet there are no Food and Drug Administration (FDA)-approved drugs to prevent it. Here, we screened 162 small-molecule kinase-specific inhibitors for reduction of cisplatin toxicity
I L Konorova et al.
Patologicheskaia fiziologiia i eksperimental'naia terapiia, (4)(4), 7-9 (1991-07-01)
The search for antiaggregatory compounds is undertaken, as a rule, under in vitro conditions which do not reflect the dynamics of the real process. The present work deals with study of the peculiarities of the development of the collagen induced
P I Polimeni et al.
Journal of cardiovascular pharmacology, 14(3), 374-380 (1989-09-01)
The acute hemodynamic effects of an intravenously (i.v.) injected poly(ethylene oxide), Polyox WSR N-60K (dose 50 mg/kg), were studied in the open-chest rat anesthetized with sodium pentobarbital. The injectate is one of four drag-reducing polymers known to augment in vitro
M Patel Geeta et al.
Current drug delivery, 6(2), 159-165 (2009-05-20)
Carbamazepine indicated for the control of epilepsy, undergoes extensive hepatic first-pass metabolism after oral administration. A vaginal dosage form of carbamazepine is not commercially available. Conventional suppository having poor retention in the vaginal tract, as they are removed in a
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service